U
Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
D
Sell
12/2/2024Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 12/2/2024 due to an increase in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 12/2/2024 due to an increase in the volatility index and total return index.
D
Sell
11/15/2024Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 11/15/2024 due to a decline in the volatility index and efficiency index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 11/15/2024 due to a decline in the volatility index and efficiency index.
D
Sell
9/11/2024Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 9/11/2024 due to an increase in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 9/11/2024 due to an increase in the volatility index and total return index.
D
Sell
8/23/2024Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 8/23/2024 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 8/23/2024 due to a decline in the volatility index.
D
Sell
8/2/2024Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 8/2/2024 due to a noticeable increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 8/2/2024 due to a noticeable increase in the volatility index.
D
Sell
7/18/2024Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 7/18/2024 due to a noticeable decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 7/18/2024 due to a noticeable decline in the volatility index.
D
Sell
7/1/2024Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 7/1/2024 due to an increase in the total return index, efficiency index and volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 7/1/2024 due to an increase in the total return index, efficiency index and volatility index.
D
Sell
8/21/2023Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 8/21/2023 due to a substantial increase in the efficiency index and solvency index. Net income increased 58.61% from $805.6 to $1.28M, and the quick ratio increased from 0.08 to 0.09.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 8/21/2023 due to a substantial increase in the efficiency index and solvency index. Net income increased 58.61% from $805.6 to $1.28M, and the quick ratio increased from 0.08 to 0.09.
D
Sell
8/7/2023Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 8/7/2023 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 8/7/2023 due to an increase in the volatility index.
E
Sell
7/21/2023Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 7/21/2023 due to a decline in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 7/21/2023 due to a decline in the volatility index and total return index.
D
Sell
7/6/2023Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 7/6/2023 due to an increase in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 7/6/2023 due to an increase in the volatility index and total return index.
E
Sell
6/15/2023Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 6/15/2023 due to a decline in the growth index, volatility index and total return index. EBIT declined 46.19% from $1.4M to $752, and total revenue declined 9.96% from $5.46M to $4.92M.
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 6/15/2023 due to a decline in the growth index, volatility index and total return index. EBIT declined 46.19% from $1.4M to $752, and total revenue declined 9.96% from $5.46M to $4.92M.
D
Sell
3/14/2023Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 02/23/2023.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and total return index. EBIT declined 2,586.02% from $37.2 to -$924.8, and total revenue declined 21.64% from $3.61M to $2.83M.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and total return index. EBIT declined 2,586.02% from $37.2 to -$924.8, and total revenue declined 21.64% from $3.61M to $2.83M.
D
Sell
8/19/2022Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 8/19/2022 due to a significant decline in the efficiency index. Total capital declined 2.67% from -$13.06M to -$13.4M.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 8/19/2022 due to a significant decline in the efficiency index. Total capital declined 2.67% from -$13.06M to -$13.4M.
D
Sell
8/5/2022Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 8/5/2022 due to an increase in the total return index and volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 8/5/2022 due to an increase in the total return index and volatility index.
D
Sell
7/21/2022Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 7/21/2022 due to a decline in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 7/21/2022 due to a decline in the volatility index and total return index.
D
Sell
7/6/2022Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 7/6/2022 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 7/6/2022 due to an increase in the volatility index.
D
Sell
6/21/2022Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 6/21/2022 due to a decline in the total return index, volatility index and valuation index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 6/21/2022 due to a decline in the total return index, volatility index and valuation index.
D
Sell
5/10/2022Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 5/10/2022 due to a significant increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 0.05 to 0.09, and total capital increased 19.94% from -$14.04M to -$11.24M.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 5/10/2022 due to a significant increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 0.05 to 0.09, and total capital increased 19.94% from -$14.04M to -$11.24M.
D
Sell
5/5/2022Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 05/05/2022.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 04/20/2022.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 04/20/2022.
D
Sell
1/26/2022Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 1/26/2022 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 1/26/2022 due to an increase in the volatility index.
D
Sell
1/10/2022Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 1/10/2022 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 1/10/2022 due to a decline in the volatility index.
D
Sell
12/21/2021Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 12/21/2021 due to an increase in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 12/21/2021 due to an increase in the volatility index and total return index.
D
Sell
12/3/2021Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 12/3/2021 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 12/3/2021 due to a decline in the volatility index.
D
Sell
11/17/2021Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from E+ on 11/17/2021 due to a noticeable increase in the growth index. Earnings per share increased from -$218.0342 to -$0.054, operating cash flow increased 25.26% from -$2.62M to -$1.96M, and EBIT increased 10.92% from -$2.64M to -$2.35M.
Rennova Health, Inc. (RNVA) was upgraded to D from E+ on 11/17/2021 due to a noticeable increase in the growth index. Earnings per share increased from -$218.0342 to -$0.054, operating cash flow increased 25.26% from -$2.62M to -$1.96M, and EBIT increased 10.92% from -$2.64M to -$2.35M.
E
Sell
11/8/2021Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell
8/20/2021Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 8/20/2021 due to an increase in the growth index and volatility index. Total revenue increased 242.74% from -$650.7 to $928.8, and EBIT increased 49.46% from -$5.22M to -$2.64M.
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 8/20/2021 due to an increase in the growth index and volatility index. Total revenue increased 242.74% from -$650.7 to $928.8, and EBIT increased 49.46% from -$5.22M to -$2.64M.
E
Sell
8/19/2021Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 8/19/2021 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 8/19/2021 due to a decline in the volatility index.
D
Sell
6/16/2021Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 6/16/2021 due to a noticeable decline in the growth index, valuation index and volatility index. Total revenue declined 148.59% from $1.34M to -$650.7.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 6/16/2021 due to a noticeable decline in the growth index, valuation index and volatility index. Total revenue declined 148.59% from $1.34M to -$650.7.
D
Sell
6/11/2021Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 6/11/2021 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 6/11/2021 due to an increase in the volatility index.
D
Sell
5/24/2021Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 5/24/2021 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 5/24/2021 due to a decline in the volatility index.
D
Sell
5/6/2021Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 5/6/2021 due to a substantial increase in the valuation index, growth index and volatility index. Operating cash flow increased 22.66% from -$4.35M to -$3.37M.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 5/6/2021 due to a substantial increase in the valuation index, growth index and volatility index. Operating cash flow increased 22.66% from -$4.35M to -$3.37M.
D
Sell
11/18/2020Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 11/18/2020 due to a substantial decline in the valuation index, growth index and total return index. Earnings per share declined from -$1.0437 to -$54.4595, EBIT declined 26.25% from -$3.31M to -$4.18M, and total revenue declined 5.72% from $2.07M to $1.95M.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 11/18/2020 due to a substantial decline in the valuation index, growth index and total return index. Earnings per share declined from -$1.0437 to -$54.4595, EBIT declined 26.25% from -$3.31M to -$4.18M, and total revenue declined 5.72% from $2.07M to $1.95M.
D
Sell
5/1/2020Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index, solvency index and total return index.
Rennova Health, Inc. (RNVA) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index, solvency index and total return index.
D
Sell
3/12/2020Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D+ from C- on 3/12/2020 due to a decline in the volatility index.
Rennova Health, Inc. (RNVA) was downgraded to D+ from C- on 3/12/2020 due to a decline in the volatility index.
C
Hold
2/26/2020Upgraded
Rennova Health, Inc. (RNVA) was upgraded to C- from D+ on 2/26/2020 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to C- from D+ on 2/26/2020 due to an increase in the volatility index.
D
Sell
2/24/2020Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 2/24/2020 due to a noticeable increase in the total return index, efficiency index and growth index. EBIT increased 46.91% from -$5.1M to -$2.71M, earnings per share increased from -$0.0025 to -$0.0018, and total capital increased 16.26% from -$13.95M to -$11.68M.
Rennova Health, Inc. (RNVA) was upgraded to D+ from D on 2/24/2020 due to a noticeable increase in the total return index, efficiency index and growth index. EBIT increased 46.91% from -$5.1M to -$2.71M, earnings per share increased from -$0.0025 to -$0.0018, and total capital increased 16.26% from -$13.95M to -$11.68M.
D
Sell
10/22/2019Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 10/22/2019 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 59.2% from -$1.36M to -$556.9.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 10/22/2019 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 59.2% from -$1.36M to -$556.9.
D
Sell
4/18/2019Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 4/18/2019 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 4/18/2019 due to an increase in the volatility index.
E
Sell
4/3/2019Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 4/3/2019 due to a decline in the volatility index, growth index and solvency index. Earnings per share declined from $1.9041 to $0.9671, and EBIT declined 17.64% from -$2.39M to -$2.82M.
Rennova Health, Inc. (RNVA) was downgraded to E+ from D- on 4/3/2019 due to a decline in the volatility index, growth index and solvency index. Earnings per share declined from $1.9041 to $0.9671, and EBIT declined 17.64% from -$2.39M to -$2.82M.
D
Sell
4/25/2018Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 4/25/2018 due to a substantial decline in the growth index and solvency index. Operating cash flow declined 86.55% from -$3.18M to -$5.93M, debt to equity increased from -0.7 to -0.38, and total revenue declined 7.58% from $1.41M to $1.31M.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 4/25/2018 due to a substantial decline in the growth index and solvency index. Operating cash flow declined 86.55% from -$3.18M to -$5.93M, debt to equity increased from -0.7 to -0.38, and total revenue declined 7.58% from $1.41M to $1.31M.
D
Sell
3/8/2018Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 3/8/2018 due to an increase in the volatility index.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 3/8/2018 due to an increase in the volatility index.
D
Sell
2/1/2018Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 2/1/2018 due to a decline in the volatility index and growth index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 2/1/2018 due to a decline in the volatility index and growth index.
D
Sell
11/21/2017Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 11/21/2017 due to a noticeable increase in the growth index. Total revenue increased 57.36% from $898.7 to $1.41M, and earnings per share increased from -$21.0912 to -$10.9004.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 11/21/2017 due to a noticeable increase in the growth index. Total revenue increased 57.36% from $898.7 to $1.41M, and earnings per share increased from -$21.0912 to -$10.9004.
D
Sell
9/1/2017Downgrade
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 9/1/2017 due to a decline in the growth index.
Rennova Health, Inc. (RNVA) was downgraded to D- from D on 9/1/2017 due to a decline in the growth index.
D
Sell
8/16/2017Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 8/16/2017 due to a major increase in the growth index and efficiency index. Total capital increased 95.54% from -$54.71M to -$2.44M, earnings per share increased from -$10.1487 to -$1.4142, and net income increased 78.52% from -$49.7M to -$10.68M.
Rennova Health, Inc. (RNVA) was upgraded to D from D- on 8/16/2017 due to a major increase in the growth index and efficiency index. Total capital increased 95.54% from -$54.71M to -$2.44M, earnings per share increased from -$10.1487 to -$1.4142, and net income increased 78.52% from -$49.7M to -$10.68M.
D
Sell
11/16/2016Upgraded
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 11/16/2016.
Rennova Health, Inc. (RNVA) was upgraded to D- from E+ on 11/16/2016.
E
Sell
8/1/2016Upgraded
Rennova Health, Inc. (RNVA) was upgraded to E+ from E on 8/1/2016 due to a noticeable increase in the growth index. Total revenue increased 125.91% from -$7.25M to $1.88M, earnings per share increased from -$2.1528 to -$0.29, and EBIT increased 62.78% from -$18.17M to -$6.76M.
Rennova Health, Inc. (RNVA) was upgraded to E+ from E on 8/1/2016 due to a noticeable increase in the growth index. Total revenue increased 125.91% from -$7.25M to $1.88M, earnings per share increased from -$2.1528 to -$0.29, and EBIT increased 62.78% from -$18.17M to -$6.76M.
E
Sell
5/2/2016Upgraded
Rennova Health, Inc. (RNVA) was upgraded to E from E- on 5/2/2016 due to an increase in the valuation index.
Rennova Health, Inc. (RNVA) was upgraded to E from E- on 5/2/2016 due to an increase in the valuation index.
E
Sell
3/11/2016Downgrade
Rennova Health, Inc. (RNVA) was downgraded to E- from E on 3/11/2016 due to a large decline in the volatility index and total return index.
Rennova Health, Inc. (RNVA) was downgraded to E- from E on 3/11/2016 due to a large decline in the volatility index and total return index.
E
Sell
2/1/2016None
Rennova Health, Inc. (RNVA) was downgraded to E from U on 02/01/2016.
Rennova Health, Inc. (RNVA) was downgraded to E from U on 02/01/2016.
OTC PK
03/06/2025 9:30AM Eastern
Quotes delayed
